Athos Therapeutics

United States
Torrance, California, United States, 90502

Company profile

Athos Therapeutics company profile

Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

Business identity

Phone number
310-866-5610
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
90502
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$54.3M
Last funding
Series B / $35M / 2024-02-16
Last equity funding
Series B / $35M
Founders
3
Articles
25

Founders and investors

Founders

Allan J. PantuckDimitrios IliopoulosMichael Jung